id,nct_id,sampling_method,gender,minimum_age,maximum_age,healthy_volunteers,population,criteria,gender_description,gender_based
5808508,NCT00520377,,All,18 Years,75 Years,No,,"
        Inclusion Criteria:

          -  Patients requiring two-stage unilateral maxillary sinus floor augmentation (sinus
             lift) in case of insufficient bone height in the area of the posterior maxilla, prior
             to insertion of dental implants

          -  Residual bone height at the site of planned implantation > 1 mm and < 5 mm

          -  Male and female outpatients, 18 to 75 years old

          -  Female patients must be infertile (either sterilized or postmenopausal). If a
             patient's menopausal status at screening is uncertain, levels of follicle stimulating
             hormone (FSH) should be determined. Patients with an FSH level > 25 IU/l and absence
             of menstrual bleeding > 6 months will satisfy the definition of postmenopausal status.

          -  Patient has given informed consent.

        Exclusion Criteria:

          -  Women of childbearing potential, lactating women

          -  Participation in another clinical study within 30 days prior to study start

          -  Previous participation in this study

          -  Last dental extraction (maxilla, posterior to canine) within the last 3 months

          -  Failed sinus lift surgery and previous eradictive maxillary sinus surgery

          -  Simultaneously bilateral sinus lift

          -  Legal incompetence or restricted legal competence

          -  Alcoholism, drug dependency, smoking

          -  Acute or chronic infection at the application site, e.g., sinusitis

          -  Known infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), or
             hepatitis C virus (HCV)

          -  Severe allergic rhinitis which requires permanent medication (Rosenlicht 1999)

          -  Known intolerance of or hypersensitivity to beta-TCP or rhGDF﷓-5

          -  Presence of local or systemic malignant disease or history of local or systemic
             malignant disease in the past 5 years

          -  Patients requiring chemo- or radiotherapy

          -  Previous or current radiotherapy of the head

          -  Chronic liver disorder

          -  Impaired renal function

          -  Uncontrolled, insulin-dependent diabetes mellitus

          -  Clinically relevant symptoms of thyroid dysfunction

          -  Severe hypertension (RRdiast > 110 mmHg);

          -  Clinically relevant cardiovascular disease

          -  Systemic bone disease or illness having influence on bone metabolism,

          -  Clinically relevant blood coagulation disorder,

          -  Leukopenia < 3.500 leukocytes/µL

          -  Previous or current treatment with systemic corticosteroids

          -  Previous or current therapy with drugs having any influence on bone metabolism

          -  Previous or current treatment with immunosuppressant medication
      ",,
5808510,NCT00520351,,All,17 Years,,Accepts Healthy Volunteers,,"
        Inclusion Criteria:

        A person is eligible for inclusion in the study if he/she:

          1. Is at least 17 years of age and has full legal capacity to volunteer.

          2. Has read, understood and signed an information consent letter.

          3. Is willing and able to follow instructions and maintain the appointment schedule.

          4. Is presently using either bi-weekly or monthly replacement lenses.

          5. Has symptoms of ocular dryness as determined by specific pre-screening criteria.

          6. Is correctable to a visual acuity of 6/9 or better (in each eye) with their habitual
             vision correction.

          7. Has clear corneas and no active ocular disease.

          8. Has had an ocular examination in the last two years.

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          1. Is an asymptomatic lens wearer.

          2. Is a daily disposable contact lens wearer.

          3. Is a current extended wear contact lens wearer.

          4. Currently uses one of the study lens care regimens.

          5. Has any clinically significant blepharitis.

          6. Has undergone corneal refractive surgery.

          7. Is aphakic.

          8. Has any active ocular disease.

          9. Has any systemic disease affecting ocular health.

         10. Is using any systemic or topical medications that may affect ocular health.

         11. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.

         12. Is participating in any other type of clinical or research study.
      ",,
